Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| September 29, 2020 | -- |
| September 28, 2020 | -- |
| September 25, 2020 | -- |
| September 24, 2020 | -- |
| September 23, 2020 | -- |
| September 22, 2020 | -- |
| September 21, 2020 | -- |
| September 18, 2020 | -- |
| September 17, 2020 | -- |
| September 16, 2020 | -- |
| September 15, 2020 | -- |
| September 14, 2020 | -- |
| September 11, 2020 | -- |
| September 10, 2020 | -- |
| September 09, 2020 | -- |
| September 08, 2020 | -- |
| September 04, 2020 | -- |
| September 03, 2020 | -- |
| September 02, 2020 | -- |
| September 01, 2020 | -- |
| August 31, 2020 | -- |
| August 28, 2020 | -- |
| August 27, 2020 | -- |
| August 26, 2020 | -- |
| August 25, 2020 | -- |
| Date | Value |
|---|---|
| August 24, 2020 | -- |
| August 21, 2020 | -- |
| August 20, 2020 | -- |
| August 19, 2020 | -- |
| August 18, 2020 | -- |
| August 17, 2020 | -- |
| August 14, 2020 | -- |
| August 13, 2020 | -- |
| August 12, 2020 | -- |
| August 11, 2020 | -- |
| August 10, 2020 | -- |
| August 07, 2020 | -- |
| August 06, 2020 | -- |
| August 05, 2020 | -- |
| August 04, 2020 | -- |
| August 03, 2020 | -- |
| July 31, 2020 | -- |
| July 30, 2020 | -- |
| July 29, 2020 | -- |
| July 28, 2020 | -- |
| July 27, 2020 | -- |
| July 24, 2020 | -- |
| July 23, 2020 | -- |
| July 22, 2020 | -- |
| July 21, 2020 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.